secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zomedica Corp. (ZOMDF)
CIK:        0001684144
Form:       8-K
Filed at:   2024-03-15T23:59:59+00:00
Accession:  0001654954-24-003187
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zomedica continues NYSE American listing dialogue after shareholder rejection of reverse split
--------------------------------------------------------------------------------

- Received NYSE American deficiency letter Sept 2023 for 30-day avg share price below $0.20 per Section 1003(f)(v).
- Shareholders rejected proposed 80:1 reverse stock split at Feb 28, 2024 special meeting; 67.7% majority required.
- Shares remain listed; exchange will monitor price and further deterioration could trigger delisting.
- CEO Larry Heaton cites progress and opportunities to positively impact share price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1684144/000165495424003187/0001654954-24-003187-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1684144/000165495424003187/zom_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-003187

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer